The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 06, 2021

Filed:

Jun. 02, 2018
Applicants:

Sunshine Lake Pharma Co., Ltd., Guangdong, CN;

North & South Brother Pharmacy Investment Company Limited, Hong Kong, CN;

Inventors:

Xinchang Liu, Dongguan, CN;

Qingyun Ren, Dongguan, CN;

Jianzhou Huang, Dongguan, CN;

Zhimin Xiong, Dongguan, CN;

Jinfeng Xiong, Dongguan, CN;

You Li, Dongguan, CN;

Yang Liu, Dongguan, CN;

Zhifu Zou, Dongguan, CN;

Guanghua Yan, Dongguan, CN;

Siegfried Goldmann, Wuppertal, DE;

Yingjun Zhang, Dongguan, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61P 31/20 (2006.01); A61K 31/4375 (2006.01); A61K 31/496 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/685 (2006.01); A61K 45/06 (2006.01); C07D 455/06 (2006.01); C07D 519/00 (2006.01); C07F 9/6561 (2006.01);
U.S. Cl.
CPC ...
A61K 31/444 (2013.01); A61K 31/4375 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/685 (2013.01); A61K 45/06 (2013.01); A61P 31/20 (2018.01); C07D 455/06 (2013.01); C07D 519/00 (2013.01); C07F 9/6561 (2013.01);
Abstract

A fused tricyclic compound and use thereof as a medicament, in particular as a medicament for the treatment and/or prevention of hepatitis B. Specifically, a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, wherein each variate is as defined in specification. The compound also includes a Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof as a medicament, especially as a medicament for the treatment and/or prevention of hepatitis B.


Find Patent Forward Citations

Loading…